MRP-S18A Inhibitors
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum protein kinase inhibitor that can impact the functional activity of MRP-S18A indirectly. MRP-S18A is a ribosomal protein; kinase activity can affect ribosomal function by altering the phosphorylation state of ribosomal proteins. Therefore, staurosporine can inhibit the function of MRP-S18A by modifying the phosphorylation state of ribosomal proteins. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide inhibits protein synthesis by blocking the translocation step in protein synthesis. This can decrease the functional activity of MRP-S18A by limiting its participation in protein synthesis. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor. As mTOR plays a vital role in protein synthesis, including ribosome biogenesis and translation initiation, rapamycin can indirectly inhibit the functional activity of MRP-S18A, which is involved in ribosome function. | ||||||
Emetine | 483-18-1 | sc-470668 sc-470668A sc-470668B sc-470668C | 1 mg 10 mg 50 mg 100 mg | $440.00 $900.00 $1400.00 $2502.00 | ||
Emetine blocks the elongation step of protein synthesis, which can lead to a decrease in the functional activity of MRP-S18A, due to its role in protein synthesis. | ||||||
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | $153.00 $938.00 | 5 | |
Sunitinib is a multi-targeted receptor tyrosine kinase inhibitor that can indirectly affect MRP-S18A's function by influencing multiple signaling pathways related to protein synthesis and ribosomal function. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a potent inhibitor of protein synthesis, specifically blocking the peptide bond formation. It can inhibit the function of MRP-S18A by preventing its role in protein synthesis. | ||||||
Nilotinib | 641571-10-0 | sc-202245 sc-202245A | 10 mg 25 mg | $209.00 $413.00 | 9 | |
Nilotinib is a tyrosine kinase inhibitor that can influence multiple signaling pathways related to protein synthesis and ribosomal function. Therefore, nilotinib could indirectly inhibit the functional activity of MRP-S18A. | ||||||
Homoharringtonine | 26833-87-4 | sc-202652 sc-202652A sc-202652B | 1 mg 5 mg 10 mg | $52.00 $125.00 $182.00 | 11 | |
Homoharringtonine inhibits protein synthesis by preventing the initial elongation step of protein synthesis. This could decrease the functional activity of MRP-S18A due to its role in protein synthesis. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $42.00 $214.00 $832.00 $66.00 | 394 | |
Puromycin causes premature chain termination during protein synthesis. As a result, it can decrease the functional activity of MRP-S18A, which participates in protein synthesis. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
Gefitinib is a tyrosine kinase inhibitor. Tyrosine kinases influence multiple signaling pathways related to protein synthesis and ribosomal function. Thus, gefitinib could indirectly inhibit the functional activity of MRP-S18A. | ||||||